$19.32
00.00%
Last update: 8:00 PM
15 minutes delayed
Comments
Loading...
Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF
GERMARCA
Sector
Healthcare
Region
US
AUM
9.72M
Fund Score
Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA:GERM) Quotes, Forecast and News Summary
Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA: GERM) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | 21.41 |
| AUM | 9.72M |
| Dividend | $0.22 |
| Ex-Div Date | Dec 27, 2023 |
| Volume | 224 |
| Market Cap | $27.77B |
| Mgmt Fee | 0.68% |
| P/E Ratio | 20.36 |
| Prev. Close | $19.32 |
| Low | - |
| 52 Wk Low | 15.67 |
| Shares Out | 650.00K |
| Yield | 1.17% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 3.26K |
| Beta | 0.91 |
| Avg. Expense Ratio | 0.68% |
| P/B Ratio | 1.72 |
Recent News
FAQ
How do I buy Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) stock?
You can purchase shares of Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA:GERM) through any online brokerage.
Who are Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) competitors?
There are no as such competitors for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF.
What is the target price for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) stock?
There is no analysis for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF.
What is the forecast for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) stock?
There is no analysis for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF to provide a consensus price target.
Current stock price for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM)?
The stock price for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA: GERM) is $19.32 last updated Today at July 15, 2024 at 8:00 PM EDT.
Does Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) pay a dividend?
There are no upcoming dividends for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF.
When is Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA:GERM) reporting earnings?
Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF does not have any upcoming earnings scheduled.
Is Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (GERM) going to split?
There is no upcoming split for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 17, 2020 |
| Managers | Qiao Duan Charles A. Ragauss |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
Under normal circumstances, the Fund invests at least 80 percent of its net assets (plus borrowings for investment purposes) in U.S.-listed equity securities or American Depositary Receipts (ADRs) of Treatments, Testing and Advancements Companies (as defined below). In general, the Index seeks to be comprised of companies: i) performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or ii) engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| ALNY | Alnylam Pharmaceutical... | 10.3% |
| LH | Laboratory Corporation... | 6.49% |
| DGX | Quest Diagnostics Inc | 6.10% |
| FF | Biontech Se | 4.91% |
| MRNA | Moderna therapeutics | 4.76% |
| PCVX | Vaxcyte Inc | 4.49% |
| IBRX | Immunitybio Inc. | 4.35% |
| BIO | Bio-Rad Laboratories-A... | 3.86% |
| SH | Zai Lab Ltd-adr | 3.85% |
| IMCR | Immunocore Holdings Lt... | 3.61% |